Eisai and Charles River Labs are to work together on a range of projects at Eisai’s research and development facilities in Hatfield, UK.
The collaboration will involve Charles River supporting Eisai scientists from Japan, USA and the UK on a range of synthetic and medicinal chemistry projects, including those seeking novel treatments for neurological diseases.
Charles River researchers will also take part in a medicinal chemistry project aiming to seek out new drugs for malaria effective against resistant strains of disease and address unmet need in the area, with help from the Global Health Innovative Technology Fund and Medicines for Malaria Venture.
“We expect our collaboration with Eisai will be the first of many. We’re excited to develop creative solutions, with Eisai and other partners, by bringing our scientific expertise to their site, thereby streamlining their research processes,” noted Emily Hickey, who heads up Global Discovery Services at Charles River.
Eisai says the move is an example of its commitment to open innovation and novel collaborative working practices.
